Alkeon Capital Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Alkeon Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $3.06 Million - $14.7 Million	-396,977 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $7.15 Million - $10 Million	-270,200 Reduced 40.5%	396,977 $13.5 Million
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $124,308 - $182,114	-3,798 Reduced 0.57%	667,177 $24.4 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $3.7 Million - $6.5 Million	100,000 Added 17.51%	670,975 $40.1 Million
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $5.01 Million - $10.3 Million	148,940 Added 35.29%	570,975 $23.5 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $13.7 Million - $30.2 Million	-431,512 Reduced 50.56%	422,035 $26.3 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $3.99 Million - $7.77 Million	200,000 Added 30.6%	853,547 $29 Million
Q1 2019 May 15, 2019	BUY	$20.65 - $29.55 $3.2 Million - $4.58 Million	155,000 Added 31.09%	653,547 $15.2 Million
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $2.36 Million - $4.46 Million	123,547 Added 32.95%	498,547 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$33.57 - $42.1 $12.6 Million - $15.8 Million	375,000 New	375,000 $14.5 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.